Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease

Monoamine oxidase and cholinesterase enzymes are important targets for the treatment of several neurological diseases especially depression, Parkinson disease and Alzheimer's. Here, we report the synthesis and testing of new 1,3,4-oxadiazole derivatives as novel inhibitors of monoamine oxidase...

Descripción completa

Detalles Bibliográficos
Autores principales: Naseem, Saira, Temirak, Ahmed, Imran, Aqeel, Jalil, Saquib, Fatima, Shamool, Taslimi, Parham, Iqbal, Jamshed, Tasleem, Mussarat, Tahir, Muhammad Nawaz, Shafiq, Zahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253498/
https://www.ncbi.nlm.nih.gov/pubmed/37304812
http://dx.doi.org/10.1039/d3ra01953e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253498/
https://www.ncbi.nlm.nih.gov/pubmed/37304812
http://dx.doi.org/10.1039/d3ra01953e

Ejemplares similares